Feider Stephen sold BBNX
November 5, 2026 · Form 4 insider transaction
Feider Stephen sold 382 shares of Beta Bionics, Inc. at $17.04 per share, a transaction worth $6.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
382
Price
$17.04
Total value
$6.5K
InsiderFeider Stephen
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 5, 2026
Filing dateNovember 9, 2026
Shares owned after159,378
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.; The weighted average sale price for the transaction reported was $17.036649 and the range of prices were between $17.00 and $17.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.